Mayo Clinic proceedings
-
Mayo Clinic proceedings · Oct 2022
Effectiveness of COVID-19 Booster on the Risk of Hospitalization Among Medicare Beneficiaries.
To determine the effectiveness of booster vaccinations on the risk of hospitalization with coronavirus disease 2019 (COVID-19) and how it varies by enrollee characteristics and interval from the initial vaccination to receipt of a booster. ⋯ Boosters are highly effective in the Medicare population. Approximately 69,225 hospitalizations would be prevented by boosters in the 15 million individuals aged 65 years or older currently not boosted in a period similar to the September 2020 through January 2021 period studied. Boosters provided the greatest benefits if they were received between 6 and 9 months following original vaccinations. However, boosters were associated with substantial decreases in COVID-19 hospitalizations in all categories of enrollees.
-
Mayo Clinic proceedings · Oct 2022
Acute Esophageal Necrosis: A Retrospective Cohort Study Highlighting the Mayo Clinic Experience.
To describe the clinical, endoscopic, and histologic features in patients with acute esophageal necrosis (AEN). ⋯ Acute esophageal necrosis is a serious condition observed in critically ill patients. Its endoscopic appearance can be highly variable. In patients with an unclear diagnosis, esophageal biopsies may be helpful given the characteristic histologic findings.